Search for a trial | Research with human participants

1 results

A single-center, open-label study to evaluate the absorption, distribution, metabolism, and excretion (ADME) and pharmacokinetics of LMI070 (branaplam) following a single oral dose of 140 mg [14C]branaplam in healthy male participants

Approved WMORecruitment stopped

The purpose of this study is to investigate how quickly and to what extent branaplam is absorbed and eliminated from the body (this is called pharmacokinetics). Branaplam will be labelled with Carbon-14 (14C) and is thus radioactive. In this way…